Azusa Komori

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi et al. · Clinical Colorectal Cancer · 2016 · 74 citations

Regorafenib Versus Trifluridine/tipiracil, Surgical Oncology, Retrospective Comparison +8

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

Satoshi Hamauchi, Kentaro Yamazaki, Toshiki Masuishi et al. · Clinical Colorectal Cancer · 2016 · 56 citations

Predictive Factor, Gastrointestinal Oncology, Medicine +5

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

Shigenori Kadowaki, Yasushi Yatabe, Hitoshi Hirakawa et al. · Case Reports in Oncology · 2013 · 46 citations · Full text

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

Toshiki Masuishi, Shigenori Kadowaki, Mayumi Kondo et al. · Anticancer Research · 2017 · 39 citations

CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy

Yukiya Narita, Hiroya Taniguchi, Azusa Komori et al. · Cancer Chemotherapy and Pharmacology · 2013 · 24 citations

Bevacizumab Efficacy, Medicine, Oxaliplatin-based Chemotherapy +6